The U.S. FDA had inspected the API facility, in Mekaguda here, from June 9-13 and issued Form 483 with one observation. The regulator had classified it as “voluntary action indicated” (VAI), the ...

Natco Pharma informed that the U.S. Food and Drug Administration (US FDA) has issued an EIR for its active pharmaceutical ingredient (API) division located in Mekaguda, Hyderabad, Telangana.

Vice Chairman and CEO Rajeev Nannapaneni said the company is looking for another transaction, potentially as large or even ...

Indian pharmaceutical company Natco Pharma Ltd has decided to acquire a 35.75% stake in South Africa’s Adcock Ingram ...

Hyderabad: NATCO Pharma Limited has announced that the U.S. Food and Drug Administration (USFDA) has issued an Establishment ...

On Thursday, 1644 stocks advanced, 2409 declined and 168 remained unchanged on Bombay Stock Exchange with advance decline ...

Adding to the unease, trade negotiations between India and the U.S. have reportedly hit a roadblock. With Washingtons August 1 deadline approaching, talks remain stalled over tariff reductions on key ...

Adcock Ingram surged the most on record after India’s Natco Pharma said it will acquire a stake in the South African drugmaker for about $232 million (R4 billion).

The NSE Nifty 50 and BSE Sensex opened slightly higher as HDFC Bank and Tata Consumer Products Ltd. supported the benchmark ...

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.